Close Menu

USPTO

The new litigation commenced nearly a year and a half after Illumina paid Affy a one-time $90 million payment to settle multiple suits without admitting liability.

Benitec said that the USPTO's decision not to enter the company's latest arguments into the re-examination proceedings for US Patent No. 6,573,099 was based purely on procedural grounds.

PacBio and Life Technologies, which owns VisiGen, are developing potentially rivaling real-time, single-molecule sequencing platforms, and the interference shows they claim ownership to related IP.

The USPTO named Pac Bio the senior party in a patent interference with Life Technologies regarding single-molecule sequencing technology and methods.

Strands: Mar 19, 2009

Premium

Cenix BioScience, AstraZeneca, RXi Pharmaceuticals, Dicerna Pharmaceuticals, Intradigm, US Patent and Trademark Office, Integrated DNA Technologies, VH Bio, Asuragen, Agilent Technologies, Proceedings of the National Academy of Sciences

Patent Reform Act reintroduced; FDA clears UF-developed wound care tech; GSK inks ophthalmology research pact with University College London, and more ...

On its website, the company informs customers that its service tests for the i4000377, i4000378, and i4000379 SNPs in BRCA1 and BRCA2 genes, either one of which may “influence your carrier status for breast/ovarian cancer.”

The patent, called “Fragment Complementation Assays for G Protein-Coupled Receptors and Their Signaling Pathways,” solidifies Odyssey’s position in complex-based assays, and adds depth to its IP coverage in these two areas, an Odyssey official told CBA News this week.

News Briefs: Feb 4, 2009

Premium

Cerenis, Montreal Heart Institute, UVA, Ortho Clinical, Mirna, UCSF, Case Western, Diagnostic Hybrids, iBridge Network, Ben Franklin Tech Partners, and more…

Pages

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.